{
  "age_at_initial_pathologic_diagnosis": "Age, in years, at which a condition or disease was first diagnosed.",
  "age_began_smoking_in_years": "Age, in years, that the participant began smoking.",
  "anatomic_neoplasm_subdivision": "The spatial location, subdivisions and/or atomic site name of a tumor; e.g. Rectum, Larynx, Tonsil, etc.",
  "case_barcode": "TCGA patient/case barcode; e.g. TCGA-06-0119. Provided by TCGA as bcr_patient_barcode.",
  "case_gdc_id": "GDC unique identifier for this case; e.g. 7b4ce492-ff40-4bf1-b3e8-75ff83e8746d. Provided by TCGA as bcr_patient_uuid. This identifier can be used to find more information at the GDC Data Portal (https://portal.gdc.cancer.gov/cases/7b4ce492-ff40-4bf1-b3e8-75ff83e8746d).",
  "clinical_m": "The clinical M score is a rating of metastasis, that is, how much cancer has spread to distant sites. It is based on results of tests done before surgery, such as physical exams and imaging scans; e.g. MX, M0, M1.",
  "clinical_n": "The clinical N score is a rating of the extent of cancer within nearby lymph nodes, based on results of tests done before surgery, such as physical exams and imaging scans; e.g. N1, N2, N3.",
  "clinical_stage": "The stage of the cancer, based on results of tests done before surgery, such as physical exams and imaging scans; e.g. Stage I, Stage II, Stage III, Stage IV.",
  "clinical_t": "The clinical T score is a rating of the extent of the primary tumor, based on results of tests done before surgery, such as physical exams and imaging scans; e.g. T1, T2, T3, T4.",
  "colorectal_cancer": "Indicates whether the participant has colorectal cancer; e.g. Yes, No.",
  "column_name": "Column name found in associated table type. Some columns occur across multiple table types, in which case each instance of (table_type, column_name) is represented by its own row.",
  "country_of_birth": "Participant's country of birth; e.g. Germany, United States, Canada, etc.",
  "days_to_birth": "Days since birth (a negative value, relative to the date of diagnosis which is considered to be t=0).",
  "days_to_death": "If vital_status indicates 'dead', then this is the number of days to death (a positive value) relative to the date of diagnosis.",
  "days_to_initial_pathologic_diagnosis": "The number of days to initial pathologic diagnosis.",
  "days_to_last_followup": "If vital_status indicates 'alive', then this is the number of days from the date of diagnosis to the last followup (communication contact).",
  "days_to_submitted_specimen_dx": "Numeric value to represent the day of the diagnosis for the submitted sample.",
  "disease_code": "A code representing the type of cancer. Values can be found at https://gdc.cancer.gov/resources-TCGA-users/TCGA-code-tables/TCGA-study-abbreviations; e.g. OV, GBM, LUAD.",
  "distinct_non_null_value_count": "Total number of distinct values found within the column.",
  "distinct_non_null_values": "List of distinct values found within the column, delimited by a comma. If more than 50 distinct values are found, an example list of 3 values are provided.",
  "ethnicity": "The ethnic origination of a participant, independent from race; eg. Not Hispanic or Latino, Hispanic or Latino.",
  "extrascleral_extension": "Spread of uveal melanoma beyond the sclera.",
  "gender": "Participant gender; e.g. Male, Female.",
  "gleason_score": "The Gleason Score (ranging from 1 -5) is the grade of the aggressiveness of prostate cancer. The combined Gleason Score is the primary Gleason score (for the largest area of the tumor) added to the secondary Gleason Score (for the next largest section of the tumor).",
  "h_pylori_infection": "Indicator of previous or current diagnosis of Helicobactor pylori infection; e.g. Yes, No, Never, Current.",
  "height": "Height of participant in centimeters.",
  "highest_non_null_percent": "Highest percentage of non-null column values within a single project, delimited by a comma.",
  "histological_type": "The histological type of cancer; e.g. Adenosquamous, Astrocytoma, etc.",
  "history_of_colon_polyps": "Indicator if the participant had a previous history of colon polyps as noted in the history/physical or previous endoscopic report(s); e.g. Yes, No.",
  "history_of_neoadjuvant_treatment": "Describes the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor; e.g. Yes, Pharmaceutical Treatment Prior to Resection, etc.",
  "human_papillomavirus_type": "HPV strains; e.g. HPV18, HPV45, etc.",
  "hpv_status_by_p16_testing": "Indicates whether the participant has a record of a positive finding for human papillomavirus based on p16 testing; e.g. Positive, Negative, Indeterminate. p16 testing can diagnose HPV status by measuring abundance of the p16 protein, which usually increases in cancer cells when HPV is present.",
  "hpv_status_by_ish_testing": "Indicates whether the participant has a record of a positive finding for human papillomavirus based on ISH testing; e.g. Positive, Negative, Indeterminate. In situ hybridization (ISH) testing can determine HPV status by detecting HPV DNA or mRNA in tissues.",
  "icd_10": "Alphanumeric value used to describe the disease code from the tenth version of the International Classification of Disease (ICD-10).",
  "icd_o_3_histology": "Code that represents the histology of the disease using the third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms.",
  "icd_o_3_site": "Code that represents the site of the disease using the third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms.",
  "laterality": "For tumors in paired organs, designates the side on which the cancer originates.",
  "lymphatic_invasion": "Indicator if small or thin-walled vessel invasion is present, indicating lymphatic involvement; e.g. Yes, No.",
  "lymphnodes_examined": "Indicator whether the lymph nodes were examined; e.g. Yes, No.",
  "lymphovascular_invasion_present": "Indicator if invasion of a cancer to the blood vessels and/or lymphatics invasion is present; e.g. Yes, No.",
  "margin_status": "The determination of the presence of actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient.",
  "masaoka_stage": "The text term used to describe the Masaoka staging system, a classification that defines prognostic indicators for thymic malignancies and predicts tumor recurrence.",
  "menopause_status": "A female participant's menopausal status; e.g. Post, Pre, Indeterminate, Peri.",
  "mitotic_count": "The number of mitoses identified under the microscope in tumors. The method of counting varies, according to the specific tumor examined. Usually, the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.",
  "neoplasm_histologic_grade": "Rating which expresses the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness; e.g. G1, G2, G3, G4.",
  "new_tumor_event_after_initial_treatment": "Indicates whether a patient has had a new tumor event after initial treatment; Yes, No.",
  "number_of_lymphnodes_examined": "The number of lymph nodes examined.",
  "number_of_lymphnodes_positive_by_he": "The number of lymph nodes involved with disease as determined by histological examination.",
  "number_pack_years_smoked": "The number of packs smoked per day times the number of years smoked by the participant.",
  "other_dx": "Indicator and type of other diagnosis; e.g. No; Yes, History of Prior Malignancy; Yes, History of Synchronous/Bilateral Malignancy; Both History of Synchronous/Bilateral and Prior Malignancy.",
  "pathologic_m": "The pathologic M score is a rating of metastasis, that is, how much cancer has spread to distant sites. It is based on surgery or biopsy; e.g. MX, M0, M1.",
  "pathologic_n": "The pathologic N score is a rating of the extent of cancer within nearby lymph nodes, based on surgery or biopsy; e.g. N1, N2, N3.",
  "pathologic_stage": "The stage of the cancer, based on surgery or biopsy; e.g. Stage I, Stage II, Stage III, Stage IV.",
  "pathologic_t": "The pathologic T score is a rating of the extent of the primary tumor, based on surgery or biopsy; e.g. T1, T2, T3, T4.",
  "perineural_invasion_present": "A yes/no indicator to ask if perineural invasion or infiltration of tumor or cancer is present.",
  "person_neoplasm_cancer_status": "The participant's cancer status; e.g. With Tumor, Tumor Free.",
  "pregnancies": "The number of times (including currently if it applies) that a female participant has been pregnant, regardless of outcome.",
  "pregnant_at_diagnosis": "The text term used to indicate whether the patient was pregnant at the time they were diagnosed.",
  "primary_neoplasm_melanoma_dx": "Indicates whether a person had a primary diagnosis of melanoma; e.g. Yes, No.",
  "primary_therapy_outcome_success": "Kind of outcome achieved after the completion of the initial course of treatment; e.g. Complete Remission/Response, Progressive Disease, etc.",
  "program_name": "Program name, always TCGA (The Cancer Genome Atlas) in this table.",
  "project_names": "List of all projects for which the column has non-null values, delimited by a comma.",
  "project_short_name": "Project name abbreviation; the program name appended with a project name abbreviation; e.g. TCGA-OV, etc.",
  "psa_value": "A male participant's Prostrate-Specific Antigen (PSA) value.",
  "race": "The race of a participant, independent from ethnicity; e.g. White, Black or African American, Asian, Native Hawaiian or other Pacific Islander, American Indian or Alaska Native.",
  "residual_tumor": "Status of the tissue margin following surgical resection; e.g. R0, R1, R2, RX.",
  "stopped_smoking_year": "Four-digit year that the participant stopped smoking; e.g. 2010.",
  "supratentorial_localization": "Text term to specify the location of the supratentorial tumor.",
  "tobacco_smoking_history": "Category describing current smoking status and smoking history as self-reported by a participant.; e.g. 1, 2, etc.",
  "tissue_source_site": "Tissue Source Site Code; see https://gdc.cancer.gov/resources-TCGA-users/TCGA-code-tables/tissue-source-site-codes for explanation of codes.",
  "tumor_basal_diameter": "Numeric value in millimeters for the lowest layer of a tumor.",
  "tumor_depth": "Numeric value that represents the depth of tumor invasion, measured in millimeters (mm).",
  "tumor_tissue_site": "The location on the body where the tumor exists; e.g. Brain, Ovary, Lung, etc.",
  "tumor_type": "Tumor Type; e.g. Primary, Type 1, Type 2.",
  "venous_invasion": "Indicator if large vessel or venous invasion was detected by surgery or presence in a tumor specimen; e.g. Yes, No.",
  "vital_status": "Survival state of the participant; e.g. dead, alive.",
  "weight": "Weight of participant in kilograms.",
  "year_of_initial_pathologic_diagnosis": "Four digit year of the diagnosis.",
  "year_of_tobacco_smoking_onset": "Four-digit year that the participant started smoking; e.g. 2010."
}